IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors

por Ujvari, Dorina, Malyukova, Alena, Zovko, Ana, Yektaei-Karin, Elham, Madapura, Harsha S, Keszei, Marton, Nagy, Noemi, Lotfi, Kourosh, Björn, Niclas, Wallvik, Jonas, Stenke, Leif, Salamon, Daniel
Publicado 2022

Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells

por Malyukova, Alena, Ujvari, Dorina, Yektaei-Karin, Elham, Zovko, Ana, Madapura, Harsha S., Keszei, Marton, Nagy, Noemi, Lotfi, Kourosh, Björn, Niclas, Wallvik, Jonas, Tamai, Minori, Nguyen, Thao T. T., Akahane, Koshi, Inukai, Takeshi, Stenke, Leif, Salamon, Daniel
Publicado 2021